Xpert MTB/RIF联合T-SPOT.TB检测对脊柱结核的早期诊断价值
The Early Diagnosis Value of Combined Xpert MTB/RIF and T-SPOT.TB Assays for Spinal Tuberculosis
摘要: 目的:通过统计学分析,探究利福平耐药实时荧光定量核酸扩增技术(Xpert MTB/RIF)联合结核感染T细胞斑点试验(T-SPOT.TB)对脊柱结核早期诊断的临床价值。方法:通过样本获取,回顾性收集2021年12月至2024年9月于青岛市胸科医院有疑似脊柱结核临床表现的患者65例,经确诊分为脊柱结核组(32例)和非脊柱结核组组(33例)。所有研究对象进行脓液的抗酸杆菌涂片检测、病理组织Xpert MTB/RIF和外周血T-SPOT.TB检测比较各单一检测方法和联合检测的诊断阳性率、阴性率和准确率,采用灵敏度、特异度、阳性预测值、阴性预测值和受试者工作特征曲线对各检测方法的诊断价值进行评价。结果:T-SPOT.TB、Xpert MTB/RIF、T-SPOT.TB与Xpert MTB/RIF串并联检测的阳性率分别为93.75%、81.25%、78.13%和96.88%,远高于涂片抗酸染色的阳性率43.75%。并联检测的阳性率高于串联检测及各单一检测,差异有统计学意义(P < 0.05)。T-SPOT.TB与Xpert MTB/RIF并联检测的假阴性率最低,为1.53%;Xpert MTB/RIF检测和T-SPOT.TB与Xpert MTB/RIF串联检测均无假阳性。不同检测方法对脊柱结核及非脊柱结核的诊断正确率均有统计学差异(P > 0.05)。T-SPOT.TB、Xpert MTB/RIF、T-SPOT.TB与Xpert MTB/RIF串并联检测的准确率分别为89.23%、90.77%、89.33%和90.77%,高于涂片抗酸染色的准确率63.08%,差异有统计学意义(P < 0.05)。T-SPOT.TB与Xpert MTB/RIF并联检测的特异度为96.55%,阳性预测值为96.88%,均高于串联检测和单一检测。T-SPOT.TB、Xpert MTB/RIF、T-SPOT.TB与Xpert MTB/RIF串并联检测与涂片抗酸染色相比,曲线下面积有统计学差异(P < 0.05)。并联检测的曲线下面积最大,为0.91 (0.84, 0.98),Xpert MTB/RIF检测的曲线下面积其次,为0.90 (0.84, 0.97),且两者差异无统计学意义(P > 0.05)。结论:T-SPOT.TB、Xpert MTB/RIF及其串并联检测用于脊柱结核的诊断相比涂片抗酸染色诊断效能更优,采用两者并联检测的效能最高,但若考虑成本效益,可选择Xpert MTB/RIF单一检测。
Abstract: Objective: To investigate the clinical value of combining Xpert MTB/RIF (rifampicin-resistant real-time fluorescence quantitative nucleic acid amplification detection technology) and T-SPOT.TB (Tuberculosis Infection T-Cell Spot Test) in the early diagnosis of spinal tuberculosis (STB) through statistical analysis. Methods: A retrospective collection was conducted from December 2021 to September 2024 at Qingdao Chest Hospital, involving 65 patients with clinical manifestations suggestive of spinal tuberculosis. After confirmation, the patients were divided into a spinal tuberculosis group (STB, 32 cases) and a non-spinal tuberculosis group (non-STB, 33 cases). All study subjects underwent acid-fast bacillus smear testing of pus, Xpert MTB/RIF testing of pathological tissues, and T-SPOT.TB testing of peripheral blood. The diagnostic positivity rate, negativity rate, and accuracy rate of each single detection method and combined detection were compared. The diagnostic value of each detection method was evaluated using sensitivity, specificity, positive predictive value, negative predictive value, and receiver operating characteristic (ROC) curve analysis. Results: The positive rates of T-SPOT.TB, Xpert MTB/RIF, T-SPOT.TB and Xpert MTB/RIF in series and parallel were 93.75%, 81.25%, 78.13% and 96.88%, respectively, which were significantly higher than that of acid-fast staining of sputum (43.75%). The positive rate of parallel detection was higher than that of series detection and each single detection, with statistically significant differences (P < 0.05). The false negative rate of T-SPOT.TB and Xpert MTB/RIF parallel detection was the lowest, at 1.53%. There were no false positives in either Xpert MTB/RIF detection or T-SPOT.TB and Xpert MTB/RIF tandem detection. There were statistically significant differences in the diagnostic accuracy rates of different detection methods for spinal tuberculosis and non-spinal tuberculosis (P > 0.05). The accuracy rates of T-SPOT.TB, Xpert MTB/RIF, T-SPOT.TB and Xpert MTB/RIF in series and parallel were 89.23%, 90.77%, 89.33% and 90.77%, respectively, which were higher than that of acid-fast staining of sputum (63.08%), with statistically significant differences (P < 0.05). The specificity of parallel detection of T-SPOT.TB and Xpert MTB/RIF was 96.55%, and the positive predictive value was 96.88%, both of which were higher than those of series detection and single detection. The areas under the curve of T-SPOT.TB, Xpert MTB/RIF, T-SPOT.TB and Xpert MTB/RIF in series and parallel were statistically different from that of acid-fast staining of sputum (P < 0.05). The area under the curve of parallel detection was the largest, which was 0.91 (0.84, 0.98), followed by that of Xpert MTB/RIF detection, which was 0.90 (0.84, 0.97), and there was no statistically significant difference between the two (P > 0.05). Conclusion: T-SPOT.TB, Xpert MTB/RIF and their series and parallel detections have better diagnostic efficacy for spinal tuberculosis than acid-fast staining of sputum. The efficacy of parallel detection of the two is the highest, but if cost-effectiveness is considered, Xpert MTB/RIF single detection can be selected.
文章引用:徐鹏, 赵明伟, 西永明. Xpert MTB/RIF联合T-SPOT.TB检测对脊柱结核的早期诊断价值[J]. 临床医学进展, 2025, 15(5): 1487-1494. https://doi.org/10.12677/acm.2025.1551518

参考文献

[1] 贾晨光, 高建国, 姚晓伟, 等. Xpert MTB/RIF技术在疑似脊柱结核早期诊断及利福平耐药检测中的价值研究[J]. 中华临床感染病杂志, 2018, 11(9): 689-694.
[2] 许伟元, 王文凯. TGF-β1、S100-A8、IL-17对脊柱结核的诊断价值及与ESR、CRP的关系[J]. 国际检验医学杂志, 2025, 46(5): 558-562.
[3] Karthek, V., Bhilare, P., Hadgaonkar, S., Kothari, A., Shyam, A., Sancheti, P., et al. (2021) Gene Xpert/MTB RIF Assay for Spinal Tuberculosis-Sensitivity, Specificity and Clinical Utility. Journal of Clinical Orthopaedics and Trauma, 16, 233-238. [Google Scholar] [CrossRef] [PubMed]
[4] 周莹, 胡小江, 江仲景, 等. 优化T-SPOT.TB在区分脊柱结核与其他脊柱感染中的诊断效能[J]. 中国感染控制杂志, 2024, 23(2): 148-154.
[5] 郭谦, 颜金祥, 陈江伟, 等. 术前影像学检查对脊柱感染的诊断效率分析[J]. 南昌大学学报(医学版), 2025, 65(1): 89-92.
[6] 夏浪, 张丽. CT与MRI在脊柱结核诊断和鉴别诊断中的临床应用价值[J]. 吉林医学, 2025, 46(2): 402-405.
[7] 任智博, 费骏, 娄才立, 等. S100-A8蛋白在脊柱结核患者外周血中的表达及临床意义[J]. 中国脊柱脊髓杂志, 2023, 33(1): 62-69.
[8] 倪水军, 金丹, 王海姣, 等. MRI联合血清Presepsin、CRP对脊柱结核的诊断价值[J]. 中华医院感染学杂志, 2025, 35(3): 367-372.
[9] Patel, J., Upadhyay, M., Kundnani, V., Merchant, Z., Jain, S. and Kire, N. (2020) Diagnostic Efficacy, Sensitivity, and Specificity of Xpert MTB/RIF Assay for Spinal Tuberculosis and Rifampicin Resistance. Spine, 45, 163-169. [Google Scholar] [CrossRef] [PubMed]
[10] 邝红萍, 李健康, 贾要丽, 等. Xpert MTB/RIF联合T-SPOT.TB对结核性脑膜炎的早期诊断价值[J]. 河南医学研究, 2024, 33(13): 2351-2354.
[11] Hadjipavlou, A.G., Mader, J.T., Necessary, J.T. and Muffoletto, A.J. (2000) Hematogenous Pyogenic Spinal Infections and Their Surgical Management. Spine, 25, 1668-1679. [Google Scholar] [CrossRef] [PubMed]
[12] Xu, T., Lai, Q., Qu, N., Zhang, B. and Qi, Q. (2023) Diagnostic Values of Peripheral Blood T-Cell Spot Test for Tuberculosis (T-SPOT.TB) for Spinal Tuberculosis. Surgical Infections, 24, 534-540. [Google Scholar] [CrossRef] [PubMed]
[13] Fan, J., An, J., Shu, W., Tang, K., Shang, Y., Xue, Y., et al. (2022) Impact of Xpert MTB/RIF on Outcomes of Adults Hospitalized with Spinal Tuberculosis: Findings from a Comparative Cohort in Beijing, China. Frontiers in Public Health, 10, Article 901504. [Google Scholar] [CrossRef] [PubMed]
[14] 张伟. 结核抗体、结核感染T细胞斑点试验(T-SPOT.TB)及痰涂片、痰培养联合诊断活动性肺结核的实践价值[J]. 工业微生物, 2024, 54(4): 144-146.
[15] 苏玉桂, 梁越媚, 欧阳锦仪, 等. Xpert结核分枝杆菌/利福平检测诊断肺结核和检查结核分枝杆菌利福平耐药性的应用价值分析[J]. 中国社区医师, 2024, 40(33): 116-118.
[16] 刘聪蕊, 李艳, 刘原, 等. T-SPOT.TB和Xpert MTB/RIF检测法在肺结核诊断中的比较[J]. 宁夏医科大学学报, 2022, 44(10): 1014-1018.
[17] 周子博. Xpert MTB/RIF与T-SPOT.TB在骨关节结核诊断中的应用价值[J]. 临床医学, 2020, 40(4): 44-45.
[18] 闫丽梅, 王静, 史君, 等. T-SPOT.TB检测在骨结核中的辅助诊断价值[J]. 国际检验医学杂志, 2021, 42(21): 2575-2578.
[19] 龚爱红, 王晓佳, 张佳林, 等. Gene X-pert MTB/RIF技术在脊柱结核诊断中的作用[J]. 中国病案, 2021, 22(4): 106-109.
[20] 汪锴, 张小舟, 康嗣如, 等. T-SPOT.TB检测在脊柱结核诊断及疗效评估中的价值[J]. 检验医学与临床, 2018, 15(19): 2909-2912.